Skip to main content

Prescription medicine

Betiatide Brand names: Technescan, Technetium, Kit

Betiatide (Kit) is a prescription medicine. FDA's NDC Directory lists it from 1 generic labeler.

  • Generic listed

Check it at the source: the betiatide FDA label on DailyMed (effective January 6, 2026); every betiatide label on DailyMed.

Highlights of the record

FDA label of January 6, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients.

Forms and strengths

  • 1 mg

Injection (powder) (lyophilized) for solution.

On the market

Generic approvals
No generic approved
Labelers listed (NDC)
3 of which 1 under generic applications, 2 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
1 since 2025 0 Class I among all firms' recalls; latest September 3, 2025
FAERS reports
109 through July 30, 2026

What is betiatide used for?

From the label: indications and usage

Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Source: FDA drug label (Technescan MAG3), Curium US LLC, effective January 6, 2026 (SPL set 0571c18b-1d5e-47bd-bddf-54d74ce1b442), via openFDA; the full label on DailyMed

Is there a generic for betiatide (Kit)?

No generic betiatide is approved (Drugs@FDA, October 8, 2026).

FDA's NDC Directory lists betiatide from 1 labeler under a generic (ANDA) application and from 2 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

Has betiatide been recalled?

The FDA's Enforcement Report lists 1 recall naming betiatide since 2025: 0 Class I (the most serious), 1 Class II, 0 Class III; 1 still ongoing. A recall names products and lots, not every product of the medicine.

StartedClassCompanyReason
September 3, 2025Class IISUN PHARMACEUTICAL INDUSTRIES INCFailed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026

What does the betiatide label say about other medicines?

The betiatide label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 2 other medicines name betiatide. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Tetrakis copper tetrafluoroboratewarnings and precautionsRadiation Risks Technetium Tc 99m Mertiatide Injection contributes to a patient’s overall long-term cumulative radiation exposure.

Other labels that name betiatide

Check betiatide against other medicines

Source: FDA drug label (Technescan MAG3), Curium US LLC, effective January 6, 2026 (SPL set 0571c18b-1d5e-47bd-bddf-54d74ce1b442), via openFDA; the full label on DailyMed

What do FAERS reports show for betiatide?

The FDA Adverse Event Reporting System holds 109 reports that list betiatide among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 5 are coded as a death and 12 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Drug Ineffective (a use or a product term, not a reaction)17
  • Dyspnoea (named in the label)11
  • Radioisotope Scan Abnormal9
  • Renal Scan Abnormal8
  • Syncope8
  • Tachycardia (named in the label)7
  • Drug Dispensing Error6
  • Nausea (named in the label)6

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Betiatide side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other